knowledgebanc

Insider Tip: Biodelivery Sciences Chairman Owns Accentia Biopharmaceutical

BDSI is a buy... Aug. 29 will validate my assumptions.


On Aug 18 10:31 AM mr. ouch wrote:

> It is about time in my opinion that the Hopkins group in a non direct
> way, even though of all the acquisition's it has, Accentia is the
> one started, built and designed by the Hopkins Group themselves.
> to see also the need for another quick form of Fentanyl realized
> other than the 'lollipop' is well needed and not so well documented
> or I believe known outside of the companies involved, want to be
> involves or certain people who I know are long awaiting for alternative
> forms of Fentanyl infusion into the body, either really quick or
> real moderate. The FDA recently having problems with 2 or 3 of the
> reservoir type patches, leaving only one type generic left. Which
> too me and I am in the 50% on this don't believe it'd effectiveness
> equals the reservoir type, which is still not that wonderful.
>
>
> this is an exciting mixture of drugs, companies, brilliance and expertise
> and to see what comes out of it should be interesting
>
> Staples
>
>
> check out the website for a different view, sort of!